Jay A. Nadel, MD; and George H Caug...

Jay A. Nadel, MD; and George H Caughey, MD

Mast small cavitys have been implicated in asthma and in other inflammatory diseases. Multiple physiologic and pathologic results have been ascribed to mediators that have been shown to be released from these small rooms including histamine, prostaglandin [D.sub.2], leukotrienes, and platelet-activating factor. During degranulation, enclosed spaces also release tryptic and chymotryptic proteases ("tryptases" and "chymases") extracellularly. These proteases are excessively abundant (they constitute the major protein in mast confined apartment granules and more than 20 percent of all protein in the cell) they are active outside of the small room and they are distinct from other members of their class, the serine esteroproteases. Evidence has been presented[1] suggesting that they could play a pathologic part in various inflammatory diseases, moreover no unique functions had been ascribed to these enzymes

A major reason for the lack of total structural information and the existence of unresolv controversies regarding the function of these enzyme is the difficulty in purifying significant amounts of the enzyme lately Caughey and his associates have been able to isolate and purify to homogeneity the one and the other tryptase and chymase and to begin to examine their functions. Our hypothesis is that the mast lonely dwelling proteases play a pathologic part in immunologic and inflammatory airway diseases. Our studies were facilitated from the fact that our colleagues, Dr Lazarus et al[2], have take the place ofed in propagating dog mastocytoma enclosed spaces in nude mice, so large numbers of guiltless morphologically and functionally identical solitary abode; squalids are available for study. These solitary abode; squalids resemble normal mast cells of dogs and humans,[3-5] and they release chymase and tryptase during degranulation.[6-8] We disaggregated that confined apartments and activated them with calcium ionophore A23187 using a two-stage reaction, in like manner that ionophore would not be ready in the supernatant.[2] This causes the release of tryptase and chymase together with histamine.[6]

Below we will describe any of our studies demonstrating interactions of potential biologic importance with airway soft muscle, neuropeptides, submucosal gland secretion, and epithelial enclosed space glycocalyx. In these studies, we have examined the drifts of supernatants of mastocytoma lonely dwellings as described above. Caughey and associates have been able to purify as well-as; not only-but also; not only-but; not alone-but tryptase[7] and chymase,[8] and this has enabled us to investigation the effects of the purified enzyme in various biologic systems

AIRWAY even MUSCLE CONTRACTION

Hyperresponsiveness to mast cell-derived mediators (eg histamine) is a distinctive feature of asthma, further its etiology is unknown.[9] We have studied the events of mast cell enzymes upon airway smooth muscle responsiveness. The original studies are described elsewhere.[10,11] Addition of mastocytoma supernatant to a muscle bath containing dog bronchial polished muscle greatly increased the contractile answer of the smooth muscle to histamine, an validity that was decreased by an inhibitor of mast solitary abode; squalid tryptase, aprotinin, and was diminished through nedocromil sodium. Contractile effects of acetylcholine were unaffected, suggesting that mast small cavity proteases act on airway plane muscle membranes to modify membrane potential-dependent contractile mechanisms. Incubation of the even muscle with purified tryptase alone (009 [unkeyable]g/ml) did not affect resting tension, on the other hand tryptase potentiated markedly the contractile validity of histamine. The significance of these observations is that mast confined apartment tryptase, which is released with histamine from the mast small cavity secretory granules during degranulation, causes bronchial hyperresponsiveness. Bronchial hyperresponsiveness is a hallmark of asthma, and thus, tryptase may play an important part in the pathogenesis of this disease.

CLEAVAGE OF SUBSTANCE P AND VASOACTIVE INTESTINAL PEPTIDE according to TRYPTASE AND CHYMASE

Substance P (SP) is released from sensory neuron in the airways[12,13] and is implicated as a mediator involved in neurogenic inflammation.[14] Vasoactive intestinal peptide, a neuropeptide that relaxes bronchial sleek muscle,[15] has been localized to efferent autonomic neurons[16] Studies implicate VIP as a mediator of nonadrenergic level muscle relaxation in the airways.[17] Furthermore, there is a choke association of some mast enclosed spaces and peptidergic nerve terminals.[18] Therefore, Caughey and his associates[19] examined the kinetics and sites of cleavage of SP and VIP by means of both tryptase and chymase: tryptase cleaved VIP rapidly at sum of two units sites with [k.sub.cat]/[K.sub.m] of 22 x [10sup5] [ssup-1] [Msup-1] nevertheless it had no effect in succession SP. Chymase cleaved the two SP and VIP at primarily a single site with [k.sub.cat]/[K.sub.m] of 39 x [10sup4] and 54 x [10sup4] [ssup-1] [Msup-1] respectively.[19] These differences between tryptase and chymase propose that the location and phenotype of mast lonely dwellings are important determinants of their peptidase activity. For example, 90 percent of human lung mast enclosed spaces are reported to contain tryptase alone.[20] Thus, tryptase, by dint of cleaving the bronchodilator VIP moreover not the bronchoconstrictor SP, might assist bronchospasm in asthma.